Results 201 to 210 of about 13,786 (243)

D90: The Strongest Contributor to Setting Time in Mineral Trioxide Aggregate and Portland Cement

open access: yesJournal of Endodontics, 2015
The setting times of commercial mineral trioxide aggregate (MTA) and Portland cements vary. It was hypothesized that much of this variation was caused by differences in particle size distribution.Two gram samples from 11 MTA-type cements were analyzed by laser diffraction to determine their particle size distributions characterized by their percentile ...
Laurence J. Walsh   +2 more
exaly   +7 more sources

125I Monotherapy Using D90 Implant Doses of 180 Gy or Greater

International Journal of Radiation Oncology Biology Physics, 2008
The purpose of this study was to characterize the oncologic results and toxicity profile of patients treated with (125)I implants using the dose delivered to 90% of the gland from the dose-volume histogram (D90) of greater than 144 Gy.From June 1995 to Feb 2005, a total of 643 patients were treated with (125)I monotherapy for T1-T2 prostate cancer with
Nelson N Stone   +2 more
exaly   +3 more sources

Point A vs. HR-CTV D90 in MRI-Based Cervical Brachytherapy of Small and Large Lesions

Brachytherapy, 2016
To evaluate the dosimetric benefits of MRI-based brachytherapy in small and large high-risk clinical target volume (HR-CTV) in cervical cancer.Twenty-eight fractions obtained from sixteen cervical cancer patients treated with MRI-based high-dose-rate brachytherapy with standard tandem and ovoid applicators were used; original fractions were optimized ...
Matthew M. Harkenrider   +2 more
exaly   +3 more sources

The Correlation Between D90 and Outcome for I-125 Seed Implant Monotherapy for Localised Prostate Cancer

Radiotherapy and Oncology, 2006
In 1998 Stock and Stone demonstrated a dose response relationship correlating D90 with probability of biochemical control and showed that a D90 of 140 Gy is a highly significant factor in predicting PSA relapse free survival (PSA-RFS). Although, a mean D90 of over 140 Gy was achieved in our series, there is nevertheless a normal distribution with 20 ...
Bashar Al-Qaisieh   +2 more
exaly   +3 more sources

Whole Prostate D90 and V100: A Dose–Response Analysis of 2000 Consecutive 125I Monotherapy Patients

Brachytherapy, 2014
To examine the relationship between whole prostate dose metrics and disease-free survival (DFS) after (125)I low-dose-rate prostate brachytherapy (LDR-PB).Data for the first 2000 LDR-PB monotherapy implants were extracted from a database containing patient, tumor, dosimetric, and outcomes information.
Tom Pickles   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy